The effects of hemostatic substances on the vascular tone in porcine coronary arteries and the influence of low density lipoprotein on tension were investigated. Thrombin induced a marked concentration-dependent relaxation in prostaglandin F2,-precontracted strips with intact endothelium, whereas it produced a modest constriction in endothelium-denuded arteries. Methylene blue abolished the relaxation, but indomethacin did not affect it significantly. An exposure of the intact strips to low density lipoprotein resulted in a marked inhibition of the relaxation to thrombin but did not interfere with vasodilation by sodium nitroprusside. The inhibition by low density lipoprotein was reversed completely by washing. In contrast, high density lipoprotein lacked such inhibitory effects. Adenosine diphosphate, calcium ionophore A23187, and platelet-activating factor also produced relaxation in the intact strips. An exposure of the strips to low density lipoprotein almost abolished relaxation to these substances. The inhibition was also reversible. Heat treatment or acid treatment of low density lipoprotein resulted in a complete loss of the inhibitory effects, but diisopropyl fluorophosphate treatment did not alter the effect. It is concluded that low density lipoprotein may play a new pathological role in promotion of coronary vasospasm through rapid and reversible inhibition in endotheliumdependent relaxation to hemostatic substances. (Circulation Research 1990;66:18-27) L ow density lipoprotein (LDL) is a major risk factor in coronary heart disease. The level of LDL in plasma is positively correlated to the incidence of coronary heart disease,' while that of high density lipoprotein (HDL) is inversely correlated.2 Furthermore, the causal relation between serum cholesterol level and the incidence of coronary heart disease has been confirmed by an epidemiological study.3 Thrombosis is a common finding in patients dying of coronary heart disease. A normally functioning endothelial cell is able to counteract platelet aggregation and thrombus formation through the production of prostaglandin (PG) I24 and endotheliumdependent relaxing factors (EDRF).5,6
Original Contributions
Rapid and Reversible Inhibition The effects of hemostatic substances on the vascular tone in porcine coronary arteries and the influence of low density lipoprotein on tension were investigated. Thrombin induced a marked concentration-dependent relaxation in prostaglandin F2,-precontracted strips with intact endothelium, whereas it produced a modest constriction in endothelium-denuded arteries. Methylene blue abolished the relaxation, but indomethacin did not affect it significantly. An exposure of the intact strips to low density lipoprotein resulted in a marked inhibition of the relaxation to thrombin but did not interfere with vasodilation by sodium nitroprusside. The inhibition by low density lipoprotein was reversed completely by washing. In contrast, high density lipoprotein lacked such inhibitory effects. Adenosine diphosphate, calcium ionophore A23187, and platelet-activating factor also produced relaxation in the intact strips. An exposure of the strips to low density lipoprotein almost abolished relaxation to these substances. The inhibition was also reversible. Heat treatment or acid treatment of low density lipoprotein resulted in a complete loss of the inhibitory effects, but diisopropyl fluorophosphate treatment did not alter the effect. It is concluded that low density lipoprotein may play a new pathological role in promotion of coronary vasospasm through rapid and reversible inhibition in endotheliumdependent relaxation to hemostatic substances. (Circulation Research 1990;66: [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] L ow density lipoprotein (LDL) is a major risk factor in coronary heart disease. The level of LDL in plasma is positively correlated to the incidence of coronary heart disease,' while that of high density lipoprotein (HDL) is inversely correlated.2 Furthermore, the causal relation between serum cholesterol level and the incidence of coronary heart disease has been confirmed by an epidemiological study.3 Thrombosis is a common finding in patients dying of coronary heart disease. A normally functioning endothelial cell is able to counteract platelet aggregation and thrombus formation through the production of prostaglandin (PG) I24 and endotheliumdependent relaxing factors (EDRF). 5, 6 In atherosclerotic human coronary arteries and rabbit aortas, selective attenuation of endotheliummediated vasodilation was reported by Forsterman et a17 and Bossaller et al. 8 Besides such slow effects of LDL on the arteries as seen in atherogenesis, several lines of investigation have suggested that LDL has rather rapid effects similar to hormones.9,10 LDL induces general cellular activation" through stimulation of phosphatidylinositol turnover in human vascular endothelial cells, arterial smooth muscle cells of rats, blood lymphocytes, lung fibroblasts, and human platelets.1213 Nord0y et al14 reported that cultured human endothelial cells had an inhibitory effect on platelet aggregation, and an incubation of the cells with LDL inhibited the endothelial cells' ability to modulate this platelet reaction.
Andrews and coworkers'5 demonstrated that pathophysiological concentrations of LDL inhibited acetylcholine-induced endothelium-dependent relaxation in rabbit aortic rings; the inhibition became maximal in 30 minutes and was irreversible by washing. We have previously reported that, unlike acetylcholine and histamine, thrombin produced a reproducible and consistent relaxation in strips of intact porcine coronary arteries and 1-hour exposure of the strips to porcine LDL dose dependently inhibited the relaxation. 16 The present study was undertaken to investigate further the inhibitory effect of LDL on the endothelium-dependent relaxation to hemostatic substances and to explore the mechanism underlying the inhibition by LDL in porcine coronary arteries. We report here that hemostatic substances such as thrombin, adenosine diphosphate (ADP), calcium ionophore A23187, and platelet-activating factor (PAF) produced a marked endothelium-dependent relaxation, and a brief exposure of the coronary artery to LDL abolished the relaxation reversibly. Heat and acid labile factor(s) present in LDL appear to mediate the inhibitory effects of LDL. Therefore, this study provides evidence that through the functional changes of the endothelium, but not through compositional (atherogenic) changes, LDL at pathophysiological concentration may promote the development of coronary vasospasm and thrombosis at the sites of frequent occurrence of hemostasis.
Materials and Methods Organ Bath Experiments
Left anterior descending coronary arteries (approximately 3 mm o.d.) were rapidly isolated from the hearts of adult pigs of either sex weighing approximately 120 kg and were placed in Tris-Tyrode's solution at 300 C with a millimolar composition of NaCl 158.3, KCl 4.0, CaCl2 2.0, MgCl2 1.05, Tris 8.3, and glucose 5.6, pH 7.35, and gassed with 95% 02-5% CO2. A 2-mm-wide ring segment was cut open parallel to the longitudinal axis of the ring to form a strip. The strip was mounted vertically under 1.5 g of resting tension in organ baths filled with normal Tyrode's solution at 370 C with a millimolar composition of NaCl 158.3, KCl 4.0, NaHCO3 10.0, NaH2PO4 0.42, CaCl2 2.0, MgCl2 1.05, and glucose 5.6, pH 7.35, and bubbled with 95% 02-5% CO2. For endothelium-denuded preparations, the inner surface of the arteries was gently rubbed with a moistened cotton pledget. The removal of endothelial cells from coronary strips was confirmed by the inability of substance P (10-`M) to induce relaxation and by histological examinations of endothelial integrity with a silver staining technique according to Abrol et al. 17 Isometric tension was measured by a forcedisplacement transducer and traced on a pen-writing recoder. Preparations were allowed to equilibrate for at least 2 hours before the actual experiments were started. To study relaxations, the coronary strips were first contracted with PGF2a (100 'M). Data are expressed as percentages of relaxation as 100% of PGF2a (10-5 M)-induced contraction. For LDL experiment, normal Tyrode's solution in which strips were equilibrated was replaced with the solution containing LDL (0.5 or 1 mg protein/ml). After equilibration in the LDL solution (less than 3 minutes), the strips were contracted with PGFIx. Briefly, plasma, LDL, and HDL (50 gl) were incubated for 30 minutes with the substrate solution (50 gl) at 370 C. The reaction was stopped by an addition of 2% trichloroacetic acid (80 ,ul) and centrifuged. The radioactivity in the supernatant was assayed.
Modification of LDL
To examine heat stability of the inhibitory factor(s) in LDL, LDL (1 mg protein/ml) was heated for 10, 20, 30, and 60 minutes at 600 C. For acid treatment, LDL (1.5-2.5 mg protein/ml) in normal Tyrode's solution was adjusted to pH 1-2 with 0.1N HCl and kept at room temperature for 30 minutes. Then the LDL solution was neutralized with 0.1N NaOH to pH 7.35. LDL concentration was adjusted to 1 mg protein/ml before usage. For diisopropyl fluorophosphate (DFP) treatment, LDL (1.5-2.5 mg protein/ ml) was incubated with DFP (0.5 and 5 mM) at room temperature for 1 hour in normal Tyrode's solution and then dialyzed at 40 C against three changes of the buffer overnight. Final LDL concentration was adjusted to 1 mg protein/ml. An aliquot of DFPtreated LDL was heated for 1 hour at 600 C.
Analytical Procedures
Protein was determined by a protein assay kit (Bio-Rad Laboratories, Richmond, California). Total cholesterol and free cholesterol were determined enzymatically using the Determiner TC 555 and FC 555 (Kyowa Medics, Tokyo, Japan), respectively.
Drugs
Methylene blue, indomethacin, sodium nitroprusside, ADP, theophylline, and substance P were obtained from Sigma Chemical, St. Louis, Missouri; PAF (synthetic, C16) was from Bachem, Switzerland; calcium ionophore A23187 was from Calbiochem, San Diego, California; fatty acid-free bovine serum albumin was from Armour, Kankakee, Illinois; and human thrombin was from Midori Cross, Osaka, Japan. PGF2 was supplied by Ono Pharmaceutical, Osaka, Japan. Calcium ionophore A23187 and PGF2, were dissolved in ethanol for stock solution. Indomethacin was dissolved in Na2CO3 (10-5 M). PAF was dissolved in ethanol and diluted with 0.1% fatty acid-free albumin in 0.9% NaCl. It was kept below -20°C and used within 2 weeks. All drugs were kept on ice during the experiments.
Statistical Analysis
Results are expressed as the mean+SEM for the number of experiments (indicated in parentheses) unless otherwise described. Data Table 2 were analyzed by paired t test and Student's t test, respectively.
Results

Thrombin-Induced Endothelium-Dependent Relaxation
Thrombin has a variety of biological effects on the endothelial cell22 and vascular smooth muscle cells23 as well as platelets. Recently, Ku24 reported that thrombin produced two contrasting coronary vascular effects in canines: an initial rapid vasodilation followed by a slow, prolonged vasocontraction. Effects of thrombin on porcine coronary arteries was examined. Human thrombin showed a modest contractile response in quiescent strips of porcine coronary arteries (Figure 1 , upper). The response was significantly greater in endothelium-denuded arteries than in intact arteries. In contrast, cumulative thrombin (0.03-0.5 U/ml) induced marked concentrationdependent vasodilation in intact arteries precontracted with PGF2a (10-5 M), whereas in endotheliumdenuded arteries, thrombin showed a slight contractile response (Figure 1, lower) . The relaxing effect of thrombin reached a maximum approximately 30 seconds after stimulation. The pretreatment for 60 minutes of intact artery strips with methylene blue (10-5 M), a soluble guanylate cyclase inhibitor,25 almost completely abolished thrombin (0.03-1 U/ ml)-induced vasodilation. Substance P (10-8-10-7 M)-induced vasodilation was blocked as well by the treatment, but approximately 70% of vasodilation to substance P (3 x 10-7 M) remained unblocked. The pretreatment with indomethacin (5 x 10-6 M), a cyclooxygenase inhibitor, did not significantly affect the responses. Similar endothelium-dependent relaxation by thrombin has been reported by De Mey et a126 in the canine femoral artery.
Inhibitory Effects of Low-Density Lipoprotein on the
Relaxation to Thrombin
The effects of LDL on endothelium-dependent vasodilation to thrombin were examined. A strip of the coronary artery was equilibrated for less than 3 minutes in normal Tyrode's solution containing LDL and precontracted with PGF2a. Despite remarkable relaxation to cumulative thrombin in the precontracted strips in the absence of LDL, the presence of LDL (1 mg protein/ml) in the organ bath markedly inhibited the relaxation (Figure 2 ). An addition of sodium nitroprusside (10-6 M), which stimulates directly guanylate cyclase in smooth muscle,27 resulted in a complete vasodilation, suggesting that the inhibitory effect of LDL is mediated by the endothelium. However, reduction in the LDL concentration to one half (0.5 mg protein/ml) did not exert such inhibitory effects as observed in LDL (1 mg protein/ml). Thrombin was added to the organ bath soon after the contraction with PGF20 reached a maximum (less than 10 minutes after exposure to LDL). Incubation of the strips with LDL for a prolonged time was not necessary for its inhibition, as a 1-hour incubation with LDL resulted in a degree of inhibition similar to that produced by incubation for less than 10 minutes. is shown in Table 1 . Since a normal porcine plasma cholesterol level is approximately 100 mg/dl, the concentration of LDL found to be effective in this experiment (1 mg protein/ml) will be in the pathophysiological range.
To test the possibility that LDL directly inactivated thrombin, thrombin (100 U/ml) was incubated for 1 hour with LDL (1 mg protein/ml) at 370 C, and then precontracted strips were stimulated cumulatively with the treated thrombin (0.03, 0.1, 0.3, and 0.5 U/mi).
The relaxation responses to the native and to the treated thrombin were not significantly different. The final concentrations of LDL in the organ bath containing the treated thrombin were 3 x 10`to 5 x 10-3 mg protein/ml, which were ineffective concentrations.
Reversibility of Inhibitory Effects of Low Density Lipoprotein
Because exposure of strips to LDL caused a rapid and marked inhibition of thrombin-induced endothelium-dependent relaxation, the reversibility of its effect was examined. Thrombin tests were performed in the absence and in the presence of LDL (1 mg protein/ml) and also 50 minutes after LDL was washed out with three changes of normal Tyrode's buffer (Figure 3) . The data were analyzed by paired t test. As shown in Figure 3 , the inhibitory effects of LDL were completely abolished after washing, and the endotheliumdependent relaxation to thrombin was observed as before. These results imply that the inhibitory effects of LDL are not attributable to the compositional changes in endothelial membranes through exchanges of lipids between the membrane and LDL or through the internalization of LDL into the cell but instead result from the functional changes of the endothelium through exposure of the artery to LDL.
Effects of High Density Lipoprotein on
Thrombin-Induced Endothelium-Dependent Relaxation It has been observed that HDL reduces the uptake of LDL into human endothelial cells in culture28 and counteracts various actions of LDL, including platelet activation, by antagonizing binding of LDL to the receptors.1" Therefore, the effect of HDL on the relaxation to thrombin was examined. Unlike LDL, the presence of HDL (1 mg protein/ml; see cholesterol concentration in Table 1 ) did not affect thrombininduced relaxation. Percent relaxation to thrombin (0.3 U/mi) was 83.1±+ 10.3 (7) and 79.2+12.1 (7) before and after exposure to HDL, respectively. Analysis of the data by paired t test indicated that there was no significant difference in relaxation to thrombin between the absence and the presence of HDL. This result coincided with that obtained in rabbit aorta relaxed with acetylcholine.29
Endothelium-Dependent Relaxation to Proaggregating Substances
Recently, aggregating platelets have been shown to induce endothelium-mediated vasodilation in canine coronary arteries through factors released by activated platelets.30 Therefore, it seemed appropriate to examine the direct effects of other proaggregating substances such as ADP, calcium ionophore A23187, and PAF on the endothelium. PAF produced by neutrophiles, platelets, and some tissues is a potent proaggregator, and it possesses a vasodilatory effect that is exerted through the endothelium. 31 The effects of these proaggregators were examined in precontracted strips of coronary arteries with and without the endothelium. In an intact artery, cumulative additions of ADP (10-7, 10'6 and 10-5 M) to an organ bath induced relaxation dose dependently in the presence of theophylline (10`4 M). In contrast, endothelium-denuded arteries did not respond to ADP at any concentration. Calcium ionophore A23187 (10-7 M) relaxed the precontracted intact artery to basal tone, whereas it was ineffective at any examined concentration in arteries without the endothelium. PAF (10-i M) induced endothelium-dependent relaxation in manner similar to that of calcium ionophore A23187. It should be noted that the concentrations of ADP and ionophore A23187 necessary to induce endothelium-dependent relaxation are in the same range as those necessary to induce platelet aggregation. However, concentrations of PAF necessary to induce the endothelium-dependent relaxation were 4-5 orders higher than those required for platelet aggregation. Lesser concentrations of the three agents than those described in the figure were ineffective.
Inhibition by Low Density Lipoprotein of Endothelium-Dependent Relaxation by Other Proaggregating Agents
Whether the inhibitory effect of LDL is specific to thrombin-induced endothelium-dependent relax-ation or whether LDL inhibition can be observed in endothelium-dependent relaxation by other proaggregators was tested. As shown in Figure 4a , the relaxation by ADP (10 6 and 10`5 M) was markedly inhibited by the presence of LDL (1 mg protein/ml). In contrast to partial inhibition in thrombin and ADP-induced relaxation, the same concentration of LDL completely abolished the endotheliumdependent relaxation to calcium ionophore A23187 (10-7 M) and PAF (10-`M) (Figures 4b, c ). Furthermore, the inhibition was fully reversed by washing off the LDL with normal Tyrode's solution. Thus, these results indicate that inhibitory effects of LDL can be observed in endothelium-dependent relaxation to the proaggregators examined.
Since human LDL carries approximately 80% of PAF acetylhydrolase activity in plasma, it is possible that exogenously added PAF might be inactivated by LDL. To test this possibility, PAF (10-1 M) was incubated for 1 hour with LDL (7.5 mg protein/ml Tyrode's solution), and then the vasodilatory effect of PAF was examined at 10`M. PAF-induced relaxation was significantly attenuated (percent relaxation, 23 .0+2.9 [4] ) by the incubation compared with the relaxation (86.8+7.8 [4] ) to nontreated PAF. However, incubation of PAF for less than 10 minutes with LDL (1 mg protein/ml) in an organ bath may not influence the effects.
Changes of Low Density Lipoprotein-Inhibitory Effect by Heating
In an attempt to identify the factor(s) involved in the inhibition of LDL in endothelium-dependent relaxation, heat stability was tested. Figure 5 shows the comparative effects of LDL before and after heating for 10-60 minutes at 600 C on the thrombin-induced endothelium-dependent relaxation. Heating at 600 C for 10 minutes almost completely abolished the inhibitory effect of LDL. Prolonged heating of LDL under the same condition produced results similar to those of 10 minutes' heating. When LDL was heated for 10 minutes at 600 C, thrombin-induced relaxations in the 
Changes of Low Density Llpoproten Effects by Acid Treatment
The findings 1) that thrombin stimulates the production of PAF in the endothelial cells,32 2) that LDL carries a large part of platelet-activating factor acetylhydrolase activity in human plasma,33 and 3) that the vasodilatory effect of PAF was partly deactivated by a preincubation with LDL suggest that plateletactivating factor acetylhydrolase might intervene at least partly in LDL effects. As platelet-activating factor acetylhydrolase is specifically deactivated by acid,34 LDL was kept at pH 1-2 for 30 minutes at room temperature and neutralized to pH 7.4. As shown in Table 2 , the acid treatment of LDL resulted in a complete loss of LDL-inhibitory effects as well as of platelet-activating factor acetylhydrolase activity. These results strongly indicate that LDL effects are ascribable to acid-labile factor(s) in LDL. (5) LDL, low-density lipoprotein.
Endothelium-dependent relaxation to thrombin was examined in the absence and the presence of native and acid-treated LDL (1 mg protein/ml). LDL (1.5-2.5 mg protein/ml) was incubated at room temperature with 0.1N HCl (final pH 1-2) for 30 minutes, and then LDL was neutralized with 0.1N NaOH (pH 7.35). The concentration was adjusted to 1 mg protein/ml before use. Platelet activating factor acetylhydrolase activity in native LDL was 8.035 nmol/mg protein/min. The activity in acid-treated LDL was not detectable. *p<0.001 by Student's t test.
Effects of Diisopropyl Fluorophosphate Treatment on Low Density Lipoprotein-Inhibitory Effects
Another attempt to explore the factor(s) responsible for LDL-inhibitory effects is the treatment of LDL with DFP (0.5 and 5 mM), a potent inhibitor of PAF acetylhydrolase35: serine-protease and esterhydrolase inhibitor. After the treatment at room temperature for 1 hour, excess DFP was removed by dialysis. Figure 6 shows the effect of the DFP treatment on endothelium-dependent relaxation to thrombin. Despite complete loss of the platelet-activating factor acetylhydrolase activity in DFP-treated LDL, the inhibitory effect of LDL on thrombin-induced endothelium-dependent relaxation remained intact after the DFP treatment. This inhibitory effect of DFP-treated LDL is not due to direct effect of excessive DFP on thrombin because DFP-treated LDL markedly reduced the inhibitory effect after being heated at 600 C for 1 hour.
Thus, it is suggested that heatand acid-labile and DFP-resistant substance(s) present in LDL, not HDL, are causal factor(s) for inhibition of endotheliumdependent relaxation.
Discussion
In porcine coronary arteries, vasoactive hormones such as acetylcholine and histamine did not produce sensitive inhibitory responses through the endothelium. On the other hand, substances involved in hemostasis, such as thrombin and ADP, induced marked and consistent endothelium-dependent relaxation at concentrations at which platelet aggregation occurred. In the absence of the endothelium, however, thrombin produced a modest contractile response, whereas other substances (ADP, calcium ionophore A23187, and PAF) did not affect the vascular tone of preconstricted arteries. The endothelium-dependent relaxation induced by these proaggregating substances was markedly inhibited or abolished in the presence of LDL. The preincubation of the strips of artery with LDL for long periods was not necessary to produce inhibition, and the inhibitory effect of LDL disappeared completely after the LDL was washed out. The effective concentration of LDL (1 mg protein/ml) to inhibit endotheliumdependent relaxation is about twofold that of the normal LDL level in porcine plasma and is equivalent to the level found in the pigs fed a highcholesterol diet for 10 weeks. 36 At half the concentration (0.5 mg protein/ml), LDL was ineffective. When the artery was preincubated for 1 hour with LDL (0.5, 1 mg protein/ml) in our previous study, the inhibitory response was dose dependent, and the effects remained considerable after washing. Andrews et a115 described that inhibitory effects of LDL were maintained even after 2 hours of extensive washing in the experiment in which rabbit aorta was incubated with human or rabbit LDL for 30 minutes. As LDL is taken up by the endothelial cells,28 it is conceivable that it may exert the same effect extracellularly and intracellularly, but only the extracellular effect is reversible.
In contrast to a complete block by LDL of ADP, calcium ionophore A23187, and PAF-induced relaxation, a small part of the response to thrombin always remained after exposure to LDL. Providing that the production of EDRF is dependent on extracellular Ca2' whereas that of PGI2 depends on intracellular Ca2' as shown in cultured endothelial cells,37 this remaining relaxation to thrombin may be due to PGI2. It is known that thrombin induces phosphatidylinositol turnover in cultured endothelial cells.38
Although inhibition by indomethacin of endotheliumdependent relaxation to thrombin was not significant, the relaxation tended to be smaller in the presence of indomethacin.
Endothelial cells bind thrombin at least 100 times more strongly than do smooth muscle cells and fibroblasts. 39 In addition, thrombin reportedly produces PAF in cultured endothelial cells,32 but formed PAF is not released from the cells. Our experiments showed that PAF relaxed the coronary artery through endothelium. These findings led us to speculate that the inhibitory effect of LDL on endotheliumdependent relaxation is mediated by the decomposition of PAF produced by thrombin through PAF acetylhydrolase present in LDL. Stafforini et a133 reported that 70% of PAF acetylhydrolase activity in human plasma was found in LDL fraction. Thus, to test this hypothesis, LDL was modified by acid known to specifically deactivate PAF acetylhydrolase; by DFP, a potent inhibitor of the activity; and by heating (600 C for 10 minutes). Acid treatment resulted in a complete loss of both the enzyme activity and the inhibitory effect on relaxation, whereas DFP treatment of LDL did not affect the relaxation, despite a complete loss of the enzyme activity. The disappearance of the inhibitory effect and the enzyme activity did not parallel in heat treatment. These results suggest that PAF acetylhydrolase activity is not a main factor in LDL. An alternative hypothesis for the mechanism of LDL inhibition is the activation of lysolecithin acyltransferase (LAT) by LDL in the endothelium.40 LAT activity, which was identified as the same enzyme as lecitin-cholesterol acyltransferase (LCAT),41 was demonstrated in cultured bovine endothelial cells.42 LAT inhibitors like thimerosal and p-hydroxymercuribenzoate activate the production of EDRF in rabbit thoracic and femoral arteries.43 LCAT is activated by Apo AI, whereas LAT is activated by LDL.40 Either removal of phospholipids from LDL or modification of LDL in arginine residue with cyclohexanedione44 and in lysine residue with succinic anhydride45 resulted in a complete loss of the activation property. The concept that the activation of endothelial LAT by LDL may be an underlying mechanism for the LDL-inhibitory effects is compatible with the finding that arginine and lysine modification of LDL loses the effect of LDL15 and the finding that DFP treatment did not affect the LDL effect ( Figure 6 ). If LDL activates LAT in the endothelium through supplying the substrate, the DFP treatment may not interfere with the activation property of LDL.
In conclusion, various proaggregators induce endothelium-dependent vasodilation in porcine coronary arteries, consequently increasing in local blood flow and decreasing in platelet adhesion46 and aggregation.5,6 LDL at pathophysiological concentrations instantly and reversibly abolish these vasodilations. In addition to its gradual modification of the endothelial cells with hyperlipidemic plasma as observed in atherosclerosis,7,8 LDL could instantly modify the property of the endothelial cells through its functional changes but not through compositional changes. Therefore, LDL at pathophysiological concentrations may block the defense mechanism of the endothelium against various proaggregators, and may facilitate thrombosis and coronary vasospasm.
